l e t t e r s
Known disease mechanisms in mitochondrial DNA (mtDNA) maintenance disorders alter either the mitochondrial replication machinery (POLG, POLG2 and C10orf2) 1-3 or the biosynthesis pathways of deoxyribonucleoside 5′-triphosphates for mtDNA synthesis [4] [5] [6] [7] [8] [9] [10] [11] . However, in many of these disorders, the underlying genetic defect has yet to be discovered. Here, we identify homozygous nonsense and missense mutations in the orphan gene C20orf72 in three families with a mitochondrial syndrome characterized by external ophthalmoplegia, emaciation and respiratory failure. Muscle biopsies showed mtDNA depletion and multiple mtDNA deletions. C20orf72, hereafter MGME1 (mitochondrial genome maintenance exonuclease 1), encodes a mitochondrial RecB-type exonuclease belonging to the PD-(D/E)XK nuclease superfamily. We show that MGME1 cleaves single-stranded DNA and processes DNA flap substrates. Fibroblasts from affected individuals do not repopulate after chemically induced mtDNA depletion. They also accumulate intermediates of stalled replication and show increased levels of 7S DNA, as do MGME1-depleted cells. Thus, we show that MGME1-mediated mtDNA processing is essential for mitochondrial genome maintenance.
At present, only three nuclear genes directly involved in mtDNA replication have been associated with mitochondrial disease 1-3 . Pathogenic mutations in these genes result in two molecular phenotypes, multiple mtDNA deletions (multiple mtDNA deletion disorders) and/or reduction of mtDNA copy number (mtDNA depletion syndromes, MDS). Multiple mtDNA deletion disorders and MDS are clinically and genetically overlapping entities, known collectively as mtDNA maintenance disorders. Their clinical manifestations range from severe multiorgan involvement in early childhood to tissuespecific manifestations, for example, myopathies, in late adulthood. Progressive external ophthalmoplegia (PEO) is commonly associated with these disorders, particularly the late-onset phenotypes.
We identified a Lebanese family (family I) with three children affected by a severe multisystemic mitochondrial disorder (Supplementary Fig. 1a ). Initial symptoms included ptosis in childhood followed by mild PEO, diffuse skeletal muscle wasting and weakness, profound emaciation and respiratory distress. Skeletal muscle biopsies showed scattered cytochrome c oxidase (COX)-negative fibers and ragged red fibers (RRFs) in all affected individuals. Respiratory chain enzyme activities were decreased in skeletal muscle (Supplementary Table 1 ). Mutations in mtDNA and nuclear genes associated with PEO were excluded by Sanger sequencing. To find the underlying genetic cause, we captured the exome of subject P1976 and performed massively parallel sequencing 12 . We applied several filtering steps, excluding intronic variants at non-canonical splice sites, synonymous variants and variants present in 816 exomes from individuals with unrelated diseases (Supplementary Table 2) . Assuming an autosomal recessive mode of inheritance and focusing on genes predicted to encode mitochondrial proteins 13 , this approach selected two genes, SPTLC3 and C20orf72. Unlike SPTLC3, C20orf72 harbored a homozygous nonsense mutation (c.456G>A, p.Trp152*) that was present in all affected subjects but not in healthy siblings, and both parents were heterozygous carriers (Supplementary Fig. 1a) .
In parallel, we applied targeted MitoExome sequencing 14, 15 and identified two additional affected individuals in an Italian family (family II) with the same homozygous nonsense mutation in C20orf72 (Supplementary Fig. 1b) . Haplotype analysis identified Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease l e t t e r s a homozygous region of 1.1 Mb shared by both families, suggesting that the mutation derives from a common founder (Supplementary  Table 3 ). In addition, we identified a homozygous c.698A>G (p.Tyr233Cys) mutation in a sporadic case from Germany. All subjects with C20orf72 mutations presented with markedly similar clinical and histological phenotypes ( Table 1, Supplementary Fig. 2 and Supplementary Note).
Analysis of the primary structure of the protein encoded by C20orf72, renamed MGME1, showed that it belongs to the PD-(D/E)XK nuclease superfamily 16 , a large and diverse group of enzymes having various nucleic acid cleavage activities. In addition to the principal PD−(D/ E)XK motifs I, II and III (Fig. 1a , green, yellow and blue, respectively), MGME1 contains a QhXXY motif, where h represents a hydrophobic residue and X represents any residue, characteristic of the RecB-type family 17 (Fig. 1a, red) . Three-dimensional homology modeling of the MGME1 active site based on the crystal structure of Escherichia coli RecB 18 indicated a very similar arrangement of the key catalytic residues (Fig. 1b) . The c.456G>A (p.Trp152*) mutation occurs upstream of the PD-(D/E)XK nuclease motif, such that the truncated product is very likely to not be functional. Even so, we did not observe any detectable levels of either full-length or truncated MGME1 in fibroblasts from subject P1976 (Fig. 1c) , with the latter result most likely owing to nonsense-mediated mRNA decay. The c.698A>G (p.Tyr233Cys) mutation found in the sporadic case affects a conserved amino-acid residue (Fig. 1a) . MGME1 contains a predicted N-terminal mitochondrial targeting signal, and immunohistochemical subcellular localization of green fluorescent protein (GFP)-tagged MGME1 in human fibroblasts (Fig. 1d) and cell fractionation (Supplementary Fig. 3) showed that MGME1 localizes to the mitochondria.
To clarify the molecular consequences of the MGME1 mutations, we analyzed available tissue samples for the presence of mtDNA deletions or mtDNA depletion. Long-range PCR showed the presence of multiple mtDNA deletions in the muscle biopsies from all affected individuals and in the blood and urine samples of family I (Supplementary Fig. 4) . The deletions were unusually large in comparison to those observed in individuals with POLG mutations. Quantitative assessment of deletions by single-molecule PCR revealed total deletion loads between 0.04% and 1.5% in skeletal muscle (Supplementary Table 4) , which is similar to the levels observed in individuals with POLG mutations (Supplementary Table 4) . mtDNA copy-number analysis detected substantial mtDNA depletion in all affected adults (P2061, P3737, P4050, P4052 and P931) (Fig. 2a) . Only the muscle biopsy from subject P1976, which was taken when he was 10 years old and only mildly symptomatic, had normal mtDNA copy numbers. The finding of mtDNA depletion and mtDNA deletions in skeletal muscle from individuals with MGME1 mutations suggested perturbed mtDNA maintenance as the primary cause of the mitochondrial disease in these individuals.
In addition to mtDNA depletion, we observed a relative increase in 7S DNA levels. 7S DNA is the single-stranded component of the mtDNA displacement loop (D loop) and is postulated to be an intermediate of prematurely terminated mtDNA replication. The ratios of 7S mtDNA to total mtDNA were twofold to eightfold higher compared to controls in five of the six investigated muscle tissues (Fig. 2a) and the fibroblasts from subject P1976 (Fig. 2b) . This phenomenon was also observed in cells subjected to small interfering RNA (siRNA) downregulation of MGME1 (Fig. 2b and Supplementary Fig. 5a ), suggesting a direct involvement of MGME1 in the turnover of 7S DNA. npg l e t t e r s
To rescue the phenotype of the MGME1 mutation, we transfected P1976 fibroblasts with a lentiviral wild-type MGME1 expression construct. Expression of wild-type MGME1 for 2 weeks substantially decreased the amount of 7S DNA, but it also caused more general mtDNA depletion ( Fig. 2c and Supplementary Fig. 5b ). Depletion of mtDNA was also detectable in control fibroblasts after (14, 121) followed by a probe specific for 18S ribosomal DNA. Relative DNA levels were obtained by quantifying PhosphorImager scans of Southern blots using ImageQuant software and normalizing for the values obtained for control fibroblasts or untransfected HeLa cells (bottom). *P < 0.05, **P < 0.01, ***P < 0.001; two-tailed Student's t test; n = 3; error bars = 1 s.d. (c) Relative mtDNA copy numbers and 7S DNA/mtDNA ratios in fibroblasts from an individual with a MGME1-null mutation (P1976; cell passage 6-10) and a control. Where indicated, fibroblasts were transduced with low (+) or high (+++) titer of a lentivirus encoding MGME1. *P < 0.05, **P < 0.01; two-tailed Student's t test; n = 3; error bars = 1 s.d. Relative DNA levels (a.u.) ** * ** ** ** ** npg l e t t e r s lentiviral expression of wild-type MGME1. These findings imply that an optimal level of MGME1 is critical for the proper maintenance of the mitochondrial genome.
To investigate the enzymatic properties of MGME1, we isolated the recombinant protein from human mitochondria by affinity purification (Supplementary Fig. 6 ). MGME1 cleaved single-stranded DNA (ssDNA) but not single-stranded RNA (ssRNA) or RNA-DNA hybrids. The enzyme required free nucleic acid ends for catalysis, as it was unable to degrade circular ssDNA (Fig. 3a) or double-stranded DNA (dsDNA) substrates containing a nick or ssDNA gap of 12 nucleotides (Supplementary Fig. 7) . The enzyme showed a strong preference for ssDNA over dsDNA (Fig. 3a) . Blocking of the 5′ end but not npg l e t t e r s the 3′ end of ssDNA with a biotin-streptavidin moiety reduced the cleavage rate to about 10-20% of that observed for unblocked control at low enzyme concentrations (Supplementary Fig. 8 ). Recombinant MGME1 processed DNA 5′-and 3′-splayed-arm and flap-like substrates by removing the ssDNA segment but stopped at the ssDNAdsDNA junction (Fig. 3b,c) . However, the flap-like substrates with a displaced 5′ DNA end were processed more efficiently than ones with a displaced 3′ end (Fig. 3d) . In addition, MGME1 processed RNA-DNA chimeric oligonucleotides by initiating DNA degradation at a position two to five nucleotides downstream from the RNA-DNA junction (Fig. 3e) . Notably, the enzyme processed splayed-arm and flap-like substrates, where the displaced 5′ arm contained RNA (Fig.  3e) . Alteration of the conserved lysine residue of the predicted PD-(D/E)XK motif III (p.Lys253Ala) completely abolished all nucleolytic activities tested ( Fig. 3 and Supplementary Fig. 6b ). We were unable to test the enzymatic activity of the enzyme variant found in the sporadic case (p.Tyr233Cys), most likely owing to impaired folding of this variant (Online Methods and Supplementary Fig. 6c ). These in vitro results confirmed the computational prediction that MGME1 is a PD−(D/E)XK-type nuclease. The requirement of nucleic acid ends with preference for the DNA 5′ end for catalysis and the ability to process DNA flap structures as well as flap structures containing RNA at the 5′ end make MGME1 a good candidate enzyme for the processing of displaced DNA containing Okazaki fragments during RNA-primed DNA synthesis on the lagging strand 19 or of DNA flaps during long-patch base excision repair 20 .
To investigate the influence of the MGME1 nonsense mutation on the ability of mtDNA to be replicated, we performed mtDNA depletion and repopulation experiments in fibroblast cultures from subject P1976. After treatment with the nucleotide analog 2′,3′-dideoxycytidine (ddC) 21 , control and mutant fibroblasts developed mtDNA depletion, with mtDNA levels falling to <10% of the untreated steady-state level within 12 d of exposure (Fig. 4a) . This depletion occurs because ddC acts both as a competitive inhibitor of mtDNA polymerase and as a terminator of nascent strand elongation 21 . After ddC withdrawal (Fig. 4a) , mtDNA repopulation was severely impaired in MGME1-null cells (only 8% of control mtDNA copy number was reached after 16 d of culture without ddC). This clearly indicates perturbed mtDNA replication, similar to that observed in individuals with pathogenic POLG mutations 22 . Notably, the mtDNA depletion rate after exposure to ddC was considerably slower in the MGME1-null cells than in controls, suggesting impaired mtDNA breakdown 22 .
To further examine the consequence of the MGME1 nonsense mutation on mtDNA replication, we analyzed the pattern of mitochondrial replication intermediates in fibroblasts from affected individuals using two-dimensional agarose gel electrophoresis (2D-AGE). We observed pronounced replication stalling and accumulation of replication intermediates in the P1976 fibroblasts but not in control fibroblasts (Fig. 4b) . These higher amounts of stalled mtDNA replication intermediates were also detected in HeLa cells subjected to siRNA targeting MGME1, and replication stalling was present throughout the entire mtDNA molecule (Fig. 4c) . A similar mtDNA replication defect in 2D-AGE has been reported for mutations in C10orf2 (Twinkle) and POLG 23 .
In conclusion, our findings imply that mtDNA processing by MGME1 is essential for effective mtDNA synthesis. Most notably, we show that mutations affecting this mitochondrial exonuclease affect proper mtDNA maintenance (Fig. 4d) and are a clinically relevant cause of mtDNA disorders. Thus far, only two nuclear nucleases have also been shown to be present in mitochondria (FEN1 and DNA2) 20, [24] [25] [26] , and one mitochondrial enzyme (ExoG) 27 has been proposed to be involved in mtDNA flap processing. Studies on mitochondrial forms of FEN1 and DNA2 as well as ExoG have focused on their role in long-patch base excision repair in mitochondria, and nothing is known about their contribution to mtDNA replication. Although, in principle, MGME1 might have a redundant role in mtDNA repair, to our knowledge, it is the first identified mitochondrial exonuclease shown to be involved in mtDNA replication, likely through the processing of displaced DNA or RNA-DNA flap-like structures during mtDNA synthesis.
URLs. MITOMAP, http://www.mitomap.org/; HGMD (Human Gene Mutation Database), http://www.hgmd.cf.ac.uk/.
METHoDS
Methods and any associated references are available in the online version of the paper.
oNLINE METHoDS
Mutation screening. Exome sequencing of the index subject of family I (P1976) was performed on a Genome Analyzer IIx system (Illumina) after in-solution enrichment of exonic sequences (SureSelect Human All Exon 38Mb kit, Agilent). The sample was sequenced using two lanes of a flow cell as 54-bp paired-end runs. Read alignment was performed with Burrows-Wheeler Aligner (BWA, version 0.5.8) to the human genome assembly hg19. Singlenucleotide variants and small insertions and deletions were detected with SAMtools (v 0.1.7). Variant annotation was performed with custom scripts. Considering the context of a mitochondrial disorder, we focused on genes encoding proteins with confirmed or predicted mitochondrial localization corresponding to a MitoP2 score of >0. 5 (ref. 13) . Sequence analysis by Sanger sequencing confirmed the presence of the c.456G>A mutation in C20orf72 in the homozygous state in all three affected siblings from family I.
The homozygous nonsense mutation (c.456G>A, p.Trp152*) in subject P4052 from family II was detected by a MitoExome sequencing approach described previously 15 . Briefly, DNA was extracted from blood, and hybrid selection (Agilent SureSelect) was used to select for the mtDNA and coding exons of over 1,000 nuclear genes associated with mitochondrial function 15 , which were sequenced by Illumina HiSeq with paired 76-bp reads. Reads were aligned to the reference human genome assembly hg19, and variants were detected using the Genome Analysis Toolkit 29 . All variants previously associated with disease (MITOMAP and HGMD) were prioritized as were all rare variants predicted to be deleterious and consistent with a recessive mode of pathogenesis 29 . The homozygous variant c.456G>A (p.Trp152*) in C20orf72 was the only candidate mutation meeting these stringent prioritization criteria.
The homozygous c.698A>G (p.Tyr233Cys) C20orf72 mutation in subject P931 was detected in a screening of 50 German individuals with PEO by Sanger sequencing. The study was approved by the Ethical Committees of the Universities of Bonn (186/09) and Milan and the Technical University Munich, and written informed consent was obtained from all subjects.
qPCR. The copy numbers of mtDNA were determined by qPCR essentially as described previously 30 . Briefly, a segment of the mtDNA outside the 7S region was amplified using primers MT3922F25 and MT4036R26 (first number, 5′ nucleotide of primer; second number, length of primer; F, forward primer; R, reverse primer; numbering according to reference sequence NC_012920). Primers MT16520F24 and MT35R24 were used together with TaqMan probe MT16557F25 to amplify a short segment inside the 7S region of the mtDNA. C T values were defined at the inflection points of fitted sigmoid curves (four-parameter Chapman curves) and were compared to those of the single-copy nuclear gene KCNJ10 amplified by primers KIR835F19 and KIR903R19 and TaqMan probe KIR857F27 (numbering according to sequence U52155). Relative 7S/mtDNA ratios were calculated by subtracting copy numbers outside 7S from those inside 7S, dividing by copy numbers outside 7S and subsequently normalizing to the control value. Reactions were performed on a MyiQ qPCR system (Bio-Rad) using either TaqMan probes or iQ SYBR Green Supermix (Bio-Rad) under the following conditions: 95 °C for 3 min and 45 cycles of 95 °C for 15 s and 60 °C for 1 min. Primer sequences are listed in Supplementary Table 5. Detection of mtDNA deletions. Large-scale deletions of the mitochondrial genome were detected by long-range PCR using either primer pair MT5462F28 and MT45R22 or the primer pair MT15974F23 and MT15623R20 (Supplementary Table 5 ). For amplification, TaKaRa LA Taq Hot Start DNA polymerase (Takara Bio) was used under the following conditions: 95 °C for 2.5 min, 10 cycles of 92 °C for 20 s and 68 °C for 14 min, 20 cycles of 92 °C for 25 s and 68 °C for 16 min, and 72 °C for 10 min. To quantify deletion levels, a single-molecule PCR approach was used as described previously 30 . Briefly, single mtDNA deletions were amplified using the same conditions as in longrange PCR, but in 42 cycles of PCR. To estimate the amounts of total mtDNA, primers MT16520F24 and MT4833R24 were used. Total template DNA was diluted stepwise to the point where only some of the multiple identical reactions resulted in amplification products (ideally less than 50%). It is reasonable to assume that, under these conditions, each positive reaction originated from a single mtDNA molecule or a single deleted mtDNA molecule dividing the degree of dilution for single mtDNA molecules by the degree of dilution for single deleted mtDNA molecules (for example, 6 positive reactions out of 15 at dilution 10 −5 for total mtDNA and 3 positive reactions out of 15 at dilution 10 −3 for deleted mtDNA gives a deletion ratio of 5 × 10 −3 ).
Cell culture, transduction and transfection. HeLa cells were cultured in DMEM (Gibco) supplemented with 10% FCS (Thermo Scientific), 10 U/ml penicillin and 10 µg/ml streptomycin (Gibco). Fibroblast cell lines were maintained in high-glucose DMEM (Invitrogen) supplemented with 10% FBS (Invitrogen), 200 µM uridine (Sigma) and 1% penicillin-streptomycin (Invitrogen) at 37 °C in a humidified atmosphere of 5% CO 2 .
The C20orf72 ORF was cloned into the lentiviral expression vector pLENTI6.3. The pLenti6.3/V5-TOPO vector system (Invitrogen) was used for the lentivirus-mediated expression of wild-type cDNA in skin fibroblast cell lines 31 . Transfected HEK 293 cells were maintained in DMEM containing 10% tetracycline-free FCS (Biochrom AG), 10 U/ml penicillin and 10 µg/ml streptomycin (Gibco), 50 µg/ml hygromycin (Invitrogen) and 15 µg/ml blasticidin (Invivogen). For siRNA experiments, 100,000 cells were transfected with siRNA against MGME1 or negative control (Invitrogen Stealth) using Lipofectamine RNAiMAX (Invitrogen) for 3 d and then transfected again for a further 3 d. siRNA sequences are given in Supplementary Table 5 .
Protein purification. The full-length cDNA clone for MGME1 was obtained from MRC Geneservice and cloned in-frame with a sequence encoding a Flag-Strep2 tag into the expression vector pcDNA5/FRT/TO (Invitrogen). cDNA clones for the Tyr233Cys and Lys253Ala variants of MGME1 were created by oligonucleotidedirected mutagenesis (primer sequences are given in Supplementary Table 5 ). The constructs encoding wild-type, Tyr233Cys and Lys253Ala MGME1 were transfected into HEK Flp-In T-Rex 293 cells (Invitrogen) using Cell Line Nucleofector (Lonza), applying program A-23. Transfected cells were induced to express recombinant MGME1 or its mutants with 50 ng/ml doxycycline for 48 h, after which time mitochondria were isolated by hypotonic lysis and differential centrifugation, as described previously 32 . Recombinant MGME1 protein was isolated using a gravityflow Strep-Tactin column (IBA) as described previously 32 . To assess the purity of the recombinant enzymes, Strep-Tactin-purified proteins were separated by SDS-PAGE and stained with Coomassie, and all protein bands were excised from the gels and identified by mass spectrometry. Typically, for the wild-type and Lys253Ala variants, the procedure yielded ~150 µg of recombinant enzyme that was ~95% pure, starting from 4-4.5 g of cells (Supplementary Fig. 6a,b) . Under the same conditions, the Tyr233Cys variant gave only about 1/30 of this yield, and preparations were contaminated (~90%) with the mitochondrial chaperone HSP70, suggestive of impaired folding of the recombinant Tyr233Cys protein (Supplementary Fig. 6c ).
In vitro nuclease assays. Labeled substrates (1 nmol) were incubated with the indicated amounts of purified MGME1 protein in a reaction buffer containing 10 mM Tris, pH 7.6, 20 mM MgCl 2 , 1 mM DTT and 0.1 mg/ml BSA at 37 °C for 30 min. Reactions were then snap frozen on dry ice and separated on 10% denaturing polyacrylamide gels, and gels were dried and imaged using a PhosphorImager (GE Healthcare). For streptavidin end blocking of biotinylated oligonucleotides, reactions also contained 15 mg/ml streptavidin (NEB).
DNA isolation, gel separation and hybridization. For one-dimensional gels, 3 µg of total genomic DNA was digested according to the manufacturer's instructions (NEB), separated on 0.6% agarose gels and blotted overnight onto nylon membrane (GE Magnaprobe). Membranes were hybridized with appropriate radiolabeled probes overnight at 65 °C in 7% SDS and 0.25 M sodium phosphate buffer (pH 7.6), washed with 1× SSC (150 mM sodium chloride and 15 mM sodium citrate, pH 7.0) with 0.1% SDS three times for 20 min at 65 °C and imaged using a PhosphorImager. For two-dimensional gels, total DNA was isolated from cells by sequential phenol-chloroform extraction according to established protocols 33 . Resulting DNA (10-20 µg) was digested according to the manufacturer's instructions (NEB) and separated on agarose gels according to protocols described in detail elsewhere 33 . Gels were then blotted and hybridized as described for onedimensional gels and were washed with 1× SSC three times for 20 min and then with 1× SSC with 0.1% SDS three times for 20 min. The primer sequences used to produce the probes are given in Supplementary Table 5. Antibodies. Protein blotting was performed on cell lysates and cell fractions using primary antibodies to MGME1 (Sigma, HPA040913; 1:500 dilution),
